1. Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain Cancer
   Theo Mantamadiotis, 2017, Cancers CrossRef
2. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
   Peyman Tabnak et al, 2023, Cancer Cell International CrossRef
3. The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology
   Catherine J. Landis et al, 2020, Cancer Research CrossRef
4. Tubular β-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury
   Hongyu Li et al, 2022, Cell Death & Disease CrossRef
5. FOXO3a-interacting proteins’ involvement in cancer: a review
   Zhiqiang Dong et al, 2024, Molecular Biology Reports CrossRef
6. The phenomenon of multidrug resistance in glioblastomas
   Alexandr N. Chernov et al, 2021, Hematology/Oncology and Stem Cell Therapy CrossRef
7. Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma Via Targeting MGMT
   Henggang Wu et al, 2020, NeuroMolecular Medicine CrossRef
8. Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow
   Cornelis J.F. van Noorden et al, 2022, Journal of Histochemistry & Cytochemistry CrossRef
9. Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes
   Bakiye Goker Bagca et al, 2022, Medical Oncology CrossRef
10. The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines
    Eduardo Martinez et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
11. Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
    Giuseppina Barrera et al, 2021, Antioxidants CrossRef
12. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme
    Gulten Tuncel et al, 2018, Medical Oncology CrossRef
13. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells
    Shreya Udawant et al, 2021, Cells CrossRef
14. FOXO3a in cancer drug resistance
    Ying Liu et al, 2022, Cancer Letters CrossRef
15. Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
    Xiaoting Zhou et al, 2023, Biomedicine & Pharmacotherapy CrossRef
16. Capsaicin Enhances Temozolomide-Resistant Glioblastoma Cells’ Chemosensitivity and Ferroptosis through FHOD1/IRF2 Downregulation
    Ceyhan Hacioglu et al, 2024, Journal of Food Biochemistry CrossRef
17. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells
    Stefan Salcher et al, 2019, Cells CrossRef
18. A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma
    Stefan Salcher et al, 2020, Oncogene CrossRef
19. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
    Juliana B. Vilar et al, 2022, Cancers CrossRef
20. Molecular mechanisms of drug resistance of glial tumor of brain. Part 2: Proliferation, angiogenesis, metastasis and recurrency
    Alexander N. Chernov et al, 2022, Medical academic journal CrossRef
21. Effects of fasting on FOXO3 expression as an anti-aging biomarker in the liver
    Novi Silvia Hardiany et al, 2023, Heliyon CrossRef
22. FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy
    Chuan He et al, 2021, Acta Pharmacologica Sinica CrossRef